Heparin

Manufacturing

CorMedix hit with another CRL in effort to get nod for DefenCath

The FDA has slapped troubled biotech CorMedix with its second complete response letter because of manufacturing issues with DefenCath.
Kevin Dunleavy Aug 9, 2022 10:00am

Ginkgo and Optimvia team on production of biosynthetic heparin

Jan 6, 2022 8:18am

SCA recalled 10 lots of heparin containing benzyl alcohol

Aug 20, 2020 9:30am

Fresenius limits heparin as shortages of blood thinner persist

Sep 2, 2019 7:02pm

Dongying Tiandong dinged by FDA over heparin testing

Nov 30, 2016 2:20pm